Issue 24-5, 2025

Review

https://doi.org/10.38025/2078-1962-2025-24-5-94-105

Autologous Platelet-Rich Plasma Therapy in Complex Treatment of Musculoskeletal Disorders: a Review

View article (Download PDF file)



Download XML file

ORCID Radik Z. Nurlygaianov 1,*, ORCID Lira T. Gilmutdinova 1, ORCID Julia A. Bogdanova 1, ORCID Bulat R. Gilmutdinov 1, ORCID Dinara R. Nurlygaianova2

1 Bashkir State Medical University, Ufa, Russia
2 Kazan (Volga Region) Federal University, Kazan, Russia


ABSTRACT

INTRODUCTION.  Platelet-rich plasma (PRP) therapy is a promising minimally invasive method for treating musculoskeletal disorders based on the use of platelet-rich plasma. Its relevance is due to the growth of degenerative-dystrophic joint diseases and the need for alternatives to surgical intervention.

AIM.  Analysis and generalization of modern data on the molecular mechanisms of action of autologous platelet plasma treatment, the results of recent clinical studies, as well as analysis of differentiated approaches to autologous platelet plasma treatment in various musculoskeletal pathologies, taking into account the age and clinical characteristics of patients based on high-quality scientific publications from 2020 to 2025.

MATERIALS AND METHODS.  A systematic analysis of scientific publications for 2020–2025 from the PubMed, Scopus, Web of Science, and eLIBRARY.RU databases was conducted using the keywords In Russian and English: platelet-rich plasma, PRP therapy, regenerative medicine, osteoarthritis, sports injuries, musculoskeletal disorders. The analysis included randomized trials and meta-analyses on the use of autologous platelet-rich plasma treatment for musculoskeletal disorders. The efficacy was assessed using pain scales, functional indicators, and instrumental diagnostic data. The analysis included 45 scientific publications, including 38 foreign and 7 Russian.

THE MAIN CONTENT OF THE REVIEW.  In knee osteoarthritis, a positive effect in the form of pain reduction and improved function lasting 6–12 months has been observed, offering advantages over hyaluronic acid. In the treatment of tendinopathies, especially epicondylitis, the use of PRP (autologous platelet rich plasma) shows moderate efficacy. In ligament and muscle injuries, the results are mixed. The quality of PRP, platelet concentration, and individual patient characteristics have a key influence.

CONCLUSION.  PRP therapy is effective in the comprehensive treatment of musculoskeletal pathologies, especially in osteoarthritis and tendinopathies. The autologous nature of the method ensures its safety. Standardization of protocols, large-scale studies, and development of personalized approaches are needed to improve the effectiveness of treatment and the quality of life of patients

KEYWORDS: platelet-rich plasma, platelet-rich plasma therapy, regenerative medicine, osteoarthritis

FOR CITATION:

Nurlygaianov R.Z., Gilmutdinova L.T., Bogdanova J.A., Gilmutdinov B.R., Nurlygaianova D.R. Autologous Platelet-Rich Plasma Therapy in Complex Treatment of Musculoskeletal Disorders: a Review. Bulletin of Rehabilitation Medicine. 2025; 24(5):94–105. https://doi.org/10.38025/2078-1962-2025-24-5-94-105 (In Russ.). 

FOR CORRESPONDENCE:

Radik Z. Nurlygaianov, Е-mail: radiknur@list.ru,


References:

  1. Bansal H., Leon J., Pont J.L., et al. Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: Correct dose critical for long term clinical efficacy. Scientific Reports. 2021; 11(1): 3971. https://doi.org/10.1038/s41598-021-83025-2
  2. Dejnek M., Moreira H., Płaczkowska S., et al. Leukocyte-Rich Platelet-Rich Plasma as an Effective Source of Molecules That Modulate Local Immune and Inflammatory Cell Responses. Oxidative Medicine and Cellular Longevity. 2022; 2022: 8059622. https://doi.org/10.1155/2022/8059622
  3. Everts P.A., Mazzola T., Mautner K., et al. Orthobiological PRP Therapies Are Imperative for the Advancement of Treatment Outcomes in Musculoskeletal Pathologies. Biomedicines. 2022; 10(11): 2933. https://doi.org/10.3390/biomedicines10112933
  4. Sun X., Mi L., Du G., et al. Platelet-rich plasma treatment alleviates osteoarthritis-related pain, inflammation, and apoptosis by upregulating the expression levels of microRNA-375 and microRNA-337. Immunopharmacology and Immunotoxicology. 2022; 44(1): 87–98. https://doi.org/10.1080/08923973.2021.2007263
  5. Мухамедов Д.Ю., Бочаров В.А., Ермилов О.В. К вопросу о практическом применении богатой тромбоцитами плазмы при патологии осевого скелета (обзор литературы). Вестник новых медицинских технологий. 2024; 4: 14–22. https://doi.org/10.24412/1609-2163-2024-4-14-22 [Mukhamedov D.Yu., Bocharov V.A., Ermilov O.V. On the question of the practical application of platelet-rich plasma in pathology of the axial skeleton (literature review). Journal of New Medical Technologies. 2024; 4: 14–22. https://doi.org/10.24412/1609-2163-2024-4-14-22 (In Russ.).]
  6. Леонова Е.И., Чиринскайте А.В., Сопов Ю.В. Систематический обзор безопасности и эффективности применения обогащённой тромбоцитами плазмы для лечения посттравматического остеоартрита коленного сустава. Казанский медицинский журнал. 2024; 105(4): 637–647. https://doi.org/10.17816/KMJ568204 [Leonova E.I., Chirinskaite A.V., Sopova Ju.V. A systematic review of the safety and efficacy of platelet-rich plasma for the treatment of posttraumatic knee osteoarthritis. Kazan Medical Journal. 2024; 105(4): 637–647. https://doi.org/10.17816/KMJ568204 (In Russ.).]
  7. Beaufils P., Dejour D., Filardo G., et al. ESSKA consensus initiative: why, when and how?. Journal of Experimental Orthopaedics. 2023; 10(1): 101. https://doi.org/10.1186/s40634-023-00664-2
  8. Wang L., Wei L., Ma H., et al. Is platelet-rich plasma better than hyaluronic acid in the treatment of knee osteoarthritis? A meta-analysis of randomized controlled trials. Wideochirurgia i Inne Techniki Maloinwazyjne. 2022; 17(4): 611–623. https://doi.org/10.5114/wiitm.2022.118777
  9. Gill S.S., Cenci G., Falcinelli S., et al. Platelet rich plasma and anterior cruciate ligament repair: A new frontier, or a short term adjunct. World Journal of Orthopedics. 2025; 16(1): 100693. https://doi.org/10.5312/wjo.v16.i1.100693
  10. Kunze K.N., Pakanati J.J., Vadhera A.S., et al. The Efficacy of Platelet-Rich Plasma for Ligament Injuries: A Systematic Review of Basic Science Literature With Protocol Quality Assessment. Orthopaedic Journal of Sports Medicine. 2022; 10(2): 23259671211066504. https://doi.org/10.1177/23259671211066504
  11. Zielinski M.A., Evans N.E., Bae H., et al. Safety and Efficacy of Platelet Rich Plasma for Treatment of Lumbar Discogenic Pain: A Prospective, Multicenter, Randomized, Double-blind Study. Pain Physician. 2022; 25(1): 29–34.
  12. Yu H., Zhou Z., Yu B., et al. The efficacy of platelet-rich plasma applicated in spinal fusion surgery: A meta-analysis. Frontiers in Surgery. 2022; 9: 924753. https://doi.org/10.3389/fsurg.2022.924753
  13. Симонов Р.А., Самойлов А.С., Рылова Н.В. и др. Эффективность аутологичной плазмы, обогащенной тромбоцитами, в комплексном лечении травм коленного сустава у юных футболистов. Современные вопросы биомедицины. 2024; 2: 1–11. https://doi.org/10.24412/2588-0500-2024_08_02_28 [Simonov R.A., Samoilov A.S., Rylova N.V., et al. Efficacy of autologous platelet-rich plasma in complex treatment of knee injuries in young football players. Modern issues of biomedicine. 2024; 2: 1–11. https://doi.org/10.24412/2588-0500-2024_08_02_28 (In Russ.).]
  14. Самойлов А.С., Рылова Н.В., Симонов Р.А. Применение PRP-терапии при остеоартрите коленного сустава в клинической и спортивной медицине: обзор литературы. Клинический вестник ФМБЦ им А.И. Бурназяна. 2023; 2: 5–12. https://doi.org/10.33266/2782-6430-2023-2-05-12 [Samoilov A.S., Rylova N.V., Simonov R.A. Application of PRP therapy for knee osteoarthritis in clinical and sports medicine: literature review. Clinical Bulletin of Burnasyan FMBC. 2023; 2: 5–12. https://doi.org/10.33266/2782-6430-2023-2-05-12 (In Russ.).]
  15. Ziesenitz V.C., Welzel T., van Dyk M., et al. Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years. Paediatric Drugs. 2022; 24(6): 603–655. https://doi.org/10.1007/s40272-022-00514-1
  16. Herdea A., Struta A., Derihaci R.P., et al. Efficiency of platelet-rich plasma therapy for healing sports injuries in young athletes. Experimental and Therapeutic Medicine. 2022; 23(3): 215. https://doi.org/10.3892/etm.2022.11139
  17. Зябкин И.В., Панкратов И.В., Петров М.А. и др. Перспективы диагностики и лечения минимальных травм и повреждений крупных суставов у несовершеннолетних спортсменов: современные представления. Медицина экстремальных ситуаций. 2024; 26(4): 104–113. https://doi.org/10.47183/mes.2024-26-4-104-113 [Zyabkin I.V., Pankratov I.V., Petrov M.A., et al. Perspectives of diagnostics and treatment of minimal injuries and damages of large joints in minor athletes: modern concepts. Extreme Medicine. 2024; 26(4): 104–113. https://doi.org/10.47183/mes.2024-26-4-104-113 (In Russ.).]
  18. Гасанов А.М., Байбеков А.О., Джаксымбаев Н.Б. и др. Опыт применения PRP-терапии как альтернативный метод лечения при заболеваниях опорно-двигательного аппарата. In the World of Science and Education. 2025; 15: 1–5. [Gasanov A.M., Baibekov A.O., Dzhaksymbaev N.B., et al. Experience of using PRP therapy as an alternative method of treatment for diseases of the musculoskeletal system. In the World of Science and Education. 2025; 15: 1–5 (In Russ.).]
  19. Godek P. High Volume PRP Therapy. Ortopedia, Traumatologia, Rehabilitacja. 2022; 24(1): 43–60. https://doi.org/10.5604/01.3001.0015.7806
  20. Wang Z.Y., Gao W., Zhao Y., Huang Y. Efficacy of platelet-rich plasma in the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials. Arthroscopy. 2022; 38(2): 435–448. https://doi.org/10.1016/j.arthro.2021.09.022
  21. Sun R.J., Guo L., Li P.C., Wei X.C. Platelet-rich plasma vs corticosteroid for treatment of rotator cuff tendinopathy:a Meta-analysis. Zhongguo Gu Shang. 2022; 35(12): 1170–1176. https://doi.org/10.12200/j.issn.1003-0034.2022.12.012
  22. Chen D.D., Lu C., Yuwen X., et al. Platelet-rich plasma combined with core decompression and bone grafting in the treatment of non traumatic necrosis of femoral head in ARCO stage II. Zhongguo Gu Shang. 2020; 33(11): 1048–1052. https://doi.org/10.12200/j.issn.1003-0034.2020.11.012
  23. Perkins C.A., Willimon S.C. Multiligament Knee Injuries in Young Athletes. Clinics in Sports Medicine. 2022; 41(4): 611–625. https://doi.org/10.1016/j.csm.2022.05.004
  24. Алимагомедов Ш.М., Нухулова С.А., Тагирова З.Р. PRP-терапия и нестероидные противовосполительные препараты при лечении остеоартрита плечевого сустава. Medicus. 2022; 6(48): 63–65. [Alimagomedov Sh.M., Nukhulova S.A., Tagirova Z.R. PRP therapy and non-steroidal anti-inflammatory drugs in the treatment of shoulder osteoarthritis. Medicus. 2022; 6(48): 63–65 (In Russ.).]
  25. Загородный Г.М., Платонов А.В., Самушия К.А., Ясюкевич А.С. Сочетанная PRP-терапия и профилактика рецидивов травм в спорте. Прикладная спортивная наука. 2022; 1(15): 91–99 [Zagorodny G.M., Platonov A.V., Samushiya K.A., Yasyukevich A.S. Combined PRP therapy and prevention of injury recurrence in sports. Applied Sports Science. 2022; 1(15): 91–99 (In Russ.).]
  26. Ye Eslami S., Fattah S., Taher S.A., Rezasoltani Z. Platelet-rich plasma therapy or arthroscopic surgery on repair of anterior cruciate ligament rupture. European Journal of Translational Myology. 2022; 32(3): 10538. https://doi.org/10.4081/ejtm.2022.10538
  27. Ye Z., Chen H., Qiao Y., Wu C., et al. Intra-Articular Platelet-Rich Plasma Injection After Anterior Cruciate Ligament Reconstruction: A Randomized Clinical Trial. JAMA Network Open. 2024; 7(5): e2410134. https://doi.org/10.1001/jamanetworkopen.2024.10134
  28. Hada S., Hada M., Yoshida K., et al. Conservative Treatment Using Platelet-Rich Plasma for Acute Anterior Cruciate Ligament Injuries in Highly Active Patients: A Retrospective Survey. Cureus. 2024; 16(1): e53102. https://doi.org/10.7759/cureus.53102
  29. McRobb J., Kamil K.H., Ahmed I., et al. Influence of platelet-rich plasma (PRP) analogues on healing and clinical outcomes following anterior cruciate ligament (ACL) reconstructive surgery: a systematic review. European Journal of Orthopaedic Surgery & Traumatology. 2023; 33(2): 225–253. https://doi.org/10.1007/s00590-021-03198-4
  30. Munde K., Banerjee S., Gahlot N., et al. Effect of platelet-rich plasma on healing of autologous graft after anterior cruciate ligament reconstruction: a randomized control trial. Regenerative Medicine. 2023; 18(8): 601–610. https://doi.org/10.2217/rme-2023-0108
  31. Huang H., Wang J., Liu X., et al. Progress of platelet-rich plasma in treatment of discogenic low back pain. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2023; 37(3): 377–382. https://doi.org/10.7507/1002-1892.202211047
  32. Eichler C., Üner J., Thangarajah F., et al. Platelet‐rich plasma (PRP) in oncological patients: long‐term oncological outcome analysis of the treatment of subcutaneous venous access device scars in 89 breast cancer patients. Archives of Gynecology and Obstetrics. 2022; 306(4): 1171–1176. https://doi.org/10.1007/s00404-022-06416-4
  33. Landro M.E., Martucci L.C., Margulies M., et al. Platelet-Rich Plasma for Musculoskeletal Disorders: No Infection Reported in Daily Practice. Journal of Skin and Stem Cell. 2022; 9(2): 1–6. https://doi.org/10.5812/jssc-126321
  34. Gomchok D., Ge R‐L., Wuren T. Platelets in renal disease. International Journal of Molecular Sciences. 2023; 24(19): 1–26. https://doi.org/10.3390/ijms241914724
  35. Li S., Lu Z., Wu S., et al. The dynamic role of platelets in cancer progression and their therapeutic implications. Nature Reviews Cancer. 2024; 24(1): 72–87. https://doi.org/10.1038/s41568-023-00639-6
  36. Mandel J., Casari M., Stepanyan M., et al. Beyond Hemostasis: platelet Innate Immune Interactions and Thromboinflammation. International Journal of Molecular Sciences. 2022; 23(7): 1–30. https://doi.org/10.3390/ijms23073868
  37. Riewruja K., Phakham S., Sompolpong P., et al. Cytokine Profiling and Intra-Articular Injection of Autologous Platelet-Rich Plasma in Knee Osteoarthritis. International Journal of Molecular Sciences. 2022; 23(2): 890. https://doi.org/10.3390/ijms23020890
  38. Hernigou J., Verdonk P., Homma Y., et al. Nonoperative and Operative Bone and Cartilage Regeneration and Orthopaedic Biologics of the Hip: An Orthoregeneration Network Foundation Hip Review. Arthroscopy. 2022; 38(2): 643–656. https://doi.org/10.1016/j.arthro.2021.08.032
  39. Загородный Г.М., Платонов А.В., Самушия К.А., Ясюкевич А.С. Сочетанная PRP-терапия и профилактика рецидивов травм в спорте. Прикладная спортивная наука. 2022; 1(15): 91–99 [Zagorodny G.M., Platonov A.V., Samushiya K.A., Yasyukevich A.S. Combined PRP therapy and prevention of injury recurrence in sports. Applied Sports Science. 2022; 1(15): 91–99 (In Russ.).]
  40. Thu A.C. The use of platelet-rich plasma in management of musculoskeletal pain: a narrative review. Journal of Yeungnam Medical Science. 2022; 39(3): 206–215. https://doi.org/10.12701/jyms.2022.00290
  41. Gardini G., Gregori N., Matteelli A., Castelli F. Mycobacterial skin infection. Current Opinion in Infectious Diseases. 2022; 35(2): 79–87. https://doi.org/10.1097/QCO.0000000000000820
  42. Martins C.C., Lockhart P.B., Firmino R.T., et al. Bacteremia following different oral procedures: systematic review and meta‐analysis. Oral Diseases. 2024; 30(3): 846–854. https://doi.org/10.1111/odi.14531
  43. Robles-Palazón F.J., López-Valenciano A., De Ste Croix M., Ayala F. Epidemiology of injuries in male and female youth football players: A systematic review and meta-analysis. Journal of Sport and Health Science. 2022; 11(6): 681–695. https://doi.org/10.1016/j.jshs.2021.10.002
  44. Grossen A.A., Lee B.J., Shi H.H., et al. Platelet-rich plasma injections: pharmacological and clinical considerations in pain management. Current Pain and Headache Reports. 2022; 26(10): 741–749. https://doi.org/10.1007/s11916-022-01082-2
  45. Eymard F., Louati K., Noel É., et al. Indications and contraindications to platelet-rich plasma injections in musculoskeletal diseases in case of infectious, oncological and haematological comorbidities: A 2025 formal consensus from the GRIIP (International Research Group on Platelet Injections). Knee Surgery & Related Research. 2025; 33(6): 2293–2306. https://doi.org/10.1002/ksa.12682



Creative Commons License
The content is available under the Creative Commons Attribution 4.0 License.

©


This is an open article under the CC BY 4.0 license. Published by the National Medical Research Center for Rehabilitation and Balneology.